| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |